Epigral informs about press release

05 May 2025 Evaluate
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Epigral has informed that it enclosed Press Release for Audited Financial Results - Q4 & FY2025. The said Press Release is also available at www.epigral.com in the Investor Relations section.

The above information is a part of company’s filings submitted to BSE.

Epigral Share Price

1277.10 -41.80 (-3.17%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
BASF India 3897.70
Tata Chemicals 763.85
SRF 3102.70
Pidilite Inds. 1458.40
Deepak Nitrite 1765.10
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×